Organogenesis Holdings Inc. provided earnings guidance for the Fiscal Year 2023. For the year, the company expects Net revenue between $454 million and $466 million, representing an increase of approximately 1% to 3% year-over-year, as compared to net revenue of $450.9 million for the year ended December 31, 2022. Net income between $3 million and $11 million and adjusted net income between $8 million and $16 million.